There are no items in your cart
Add More
Add More
| Item Details | Price | ||
|---|---|---|---|
Language: English
Published by: Focus Medica India Pvt Ltd.,
Validity Period: 365 days
The Animated Atlas of Lung Cancer is a comprehensive collection of 72 animated videos pertaining to the types of lung cancer, causes, progression, staging and diagnosis, and treatment options depending on the type and stage of cancer. The Animated Atlas is an excellent reference and invaluable resource for effective presentations and lectures.
| Lung cancer | |||
| Small cell carcinoma | |||
| Non-small cell lung cancer | |||
| Squamous cell carcinoma | |||
| Adenocarcinoma | |||
| Large cell carcinoma | |||
| Bronchioloalveolar carcinoma | |||
| Clear cell adenocarcinoma | |||
| Mucinous cystadenocarcinoma | |||
| Signet-ring adenocarcinoma | |||
| Large cell neuroendocrine carcinoma | |||
| Mucoepidermoid carcinoma | |||
| Basaloid carcinoma | |||
| Adenosquamous carcinoma | |||
| Mesothelioma | |||
| Carcinoid lung tumors | |||
| Superior vena cava obstruction | |||
| Pleural effusion | |||
| TNM staging of lung cancer (2:00) | |||
| Lung cancer and IGF (insulin like growth factor) (2:00) | |||
| Elevated levels of alkaline phosphatase in metastatic non-small cell lung cancer | |||
| Transforming growth factor (TGF)-β and angiogenesis (2:00) | |||
| TGF-β as tumor suppressor gene and oncogene (2:00) | |||
| Over-expression of EGF (epidermal growth factor) and angiogenesis (2:00) | |||
| JAK/STAT (janus-activated kinases/signal transducers and activators of transcription) pathway and lung cancer (2:00) | |||
| Retinoids and EGFR (epidermal growth factor receptor) | |||
| Detection of EGFR mutation in lung cancer | |||
| Superior sulcus tumors and Horner’s syndrome (2:00) | |||
| VEGF and angiogenesis in lung cancer | |||
| Tobacco smoke carcinogens and lung cancer (2:00) | |||
| COX-2 and lung cancer (2:00) | |||
| Invasion and metastasis due to up-regulation of matrix metalloproteinases | |||
| Akt activation in lung cancer (2:00) | |||
| Retinoic acid receptor-β (RAR-β) and lung cancer (2:00) | |||
| Role of cytokines in lung cancer | |||
| Ln5 genes in lung cancer | |||
| Fine needle aspiration of supraclavicular node or metastatic site (2:00) | |||
| Transbronchial needle aspiration (TNBA) of mediastinal lymph node | |||
| Thoracoscopic biopsy | |||
| Carcinogen derived biomarkers and lung cancer | |||
| Surgical resection of cancerous tumor | |||
| Cryosurgery | |||
| Interferon alpha in the treatment of lung cancer | |||
| Brachytherapy | |||
| Hyperthermia | |||
| Video assisted thoracoscopic surgery | |||
| Stereotatic body radiotherapy for lung cancer | |||
| Use of platinum-based drugs in treating non-small cell lung cancer | |||
| Use of radiofrequency ablation (RFA) in peripheral tumors | |||
| Excision repair cross-complementation group-1(ERCCG-1) and resistance to platinu | |||
| Ribonucleotide reductase subunit-1 (RRM1) and resistance to antimetabolite and platinum | |||
| KRAS mutation and resistance to monoclonal antibody therapy in non-small cell lung cancer | |||
| Anti-insulin like growth factor-1 receptor antibody for treating non-small cell lung cancer | |||
| Use of photodynamic therapy in lung cancer | |||
| Targeted genetic therapy for lung cancer | |||
| Use of COX-2 inhibitors for adenocarcinoma | |||
| Radiation therapy | |||
| Advantages of combined chemoradiation therapy | |||
| Combination of radiation therapy and chemotherapy for non-small cell lung cancer | |||
| EGFR inhibitors in non-small cell lung cancer | |||
| Targeting VEGF and VEGFR to inhibit angiogenesis in lung cancer (2:00) | |||
| Tyrosine kinase inhibitors | |||
| Gene therapy for lung cancer | |||
| Immune therapy for lung cancer (2:00) | |||
| Vaccines for lung cancer (2:00) | |||
| SRC kinase inhibitors and lung cancer (2:00) | |||
| PTEN (phosphatase and tensin homologue deleted on chromosome 10) inhibitors and lung cancer (2:00) | |||
| Anaplastic lymphoma kinase (ALK) inhibitors for non-small cell lung cancer (2:00) | |||
| Mitogen-activated protein kinase kinase (MEK) inhibitor and lung cancer | |||
| Lung cancer and antisense therapy (2:00) | |||
| Inhibition of matrix metalloproteinases | |||
| Proteasome inhibition and lung cancer (2:00) | |||
Launch your Graphy
